ML 34 (Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg)

Pill imprint ML 34 has been identified as Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg.

Hydrochlorothiazide/irbesartan is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/irbesartan 12.5 mg / 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for ML 34

Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg ML 34
Hydrochlorothiazide and irbesartan
Imprint:
ML 34
Strength:
12.5 mg / 150 mg
Color:
Peach
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):
33342-0057
Inactive Ingredients:
carboxymethylcellulose calcium
silicon dioxide
povidone k29/32
sodium starch glycolate type A potato
magnesium silicate
magnesium stearate
hypromellose 2910 (15 mPa.s)
titanium dioxide
polyethylene glycol 3000
lactose monohydrate
ferric oxide yellow
ferric oxide red

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)